U.S. market Closed. Opens in 3 hours 1 minute

GPCR | Structure Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-31
RevenueN/AN/AN/AN/A
Cost of Revenue949.17K623.26K266.35K20.03K
Gross Profit-949.17K-623.26K-266.35K-20.03K
Operating Expenses102.78M52.56M37.70K15.91K
Selling, General & Admin32.67M16.37M8.59K3.54K
Research & Development70.10M36.19M29.11K12.36K
Other Operating Expenses0N/AN/AN/A
Operating Income-102.78M-52.56M-37.70K-15.91K
Other Expenses / Income13.39M1.26M-122.00K168.00K
Before Tax Income-89.38M-51.30M-37.82K-15.74K
Income Tax Expenses236.00K17.00K231.00138.00
Net Income-89.62M-51.32M-38.05K-15.88K
Interest Expenses13.39MN/A122.16KN/A
Basic Shares Outstanding36.73M36.59M36.59M36.59M
Diluted Shares Outstanding36.73M36.59M36.59M36.59M
EBITDA-102.78M-52.28M-37.62M-15.75M
EBITDA Margin0.00%0.00%0.00%0.00%
EBIT-75.99M-51.30M84.34K-15.74K
EBIT Margin0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙